EKB Journal Management System
1.

MicroRNA Let-7a-1-5p role in EGFR, EpCAM expression of hepatocellular carcinoma progression in HBV-infected Iraqi patients

Articles in Press, Accepted Manuscript , Available Online from 11 April 2025
Khalid R Majeed; Wiaam AL-Amili Ahmed; Safaa A. A. Al-Waysi
2.

Impact of Cetuximab Addition to FOLFIRI as First-Line Therapy for Metastatic Colorectal Cancer on Patient Quality of Life

Articles in Press, Accepted Manuscript , Available Online from 05 October 2025
Mohamed Ibrahim; Mohamed Abdeen; Hesham Elwekel; Hesham Elghazaly; Soha Abbas
3.

Assessment of Serum C-Terminal Agrin Fragment in Chronic Kidney Disease Patients

Volume 31, Issue 10, October 2025, Pages 5036-5043
Fatma M. Attia Elsayed; Ezzat Moustafa Mohammed; Sally Mahmoud Saeed Shalaby; Hala M. Allam; Niveen Shafeek Shokry Sakla; Aya Moustafa Metwally Mohammed; Fatima El Taher Taha
4.

Genetic Variants of EGFR and EpCAM in association with HCC Susceptibility in HBV Infected Iraqi Patients

Volume 34, Issue 2, April 2025, Pages 159-167
Khalid R. Majeed; Wiaam A. AL-Amili; Safaa A.A. Al-Waysi
5.

Factors Affecting the Decision to Initiate Dialysis: A Survey of Qalubia Governorate Nephrologists

Volume 42, Issue 4, April 2025, Pages 634-643
Ahmed Ayman Ahmed Wahdan; Hassan Galal Abdelsalam; Mohamed E.Ibrahim; Dina Ahmed Younis; ahmed ezzat mansour
6.

Molecular Evaluation of the Therapeutic Potential of DNA-Based Vaccines Against Experimentally Induced Lung Cancer

Volume 11, Issue 1, March 2025, Pages 20-36
S. E. Hassab El-Nabi; Abdel Aziz A. Zidan; Nourhan K. El. Ghayesh; Karolin K. Abdel Aziz; EL Hassan M. Mokhamer
7.

1,2,3-Triazole-Based Hybrids as EGFR Inhibitors: An overview

Volume 9, Issue 1, March 2025, Pages 84-91
Asmaa SA Yassen; Nareman A. Nawareg; Ebtehal M. Husseiny; Magda A. A. El-Sayed; Hosam A. Elshihawy
8.

Investigating Nitrogen Containing Compounds as Promising Anticancer Agents

Volume 9, Issue 1, March 2025, Pages 113-122
Noura Zakaria Elzoghbi; Safaa Kishk; khaled Mohamed Darwish; Ismail Salama
9.

The Predictive Role of Key MAPK Pathway Variants in Differentiated Thyroid Cancer Patients’ Response to Radioactive Iodine Therapy

Volume 31, Issue 1, January 2025, Pages 543-554
Shaymaa E. El Feky; Tarek M. Salem; Omr S. Zahra; Magdi A. Ali; Ibrahim H. Abo El Azm; Hadeer M. Dosouky; Mohamed I. Morsi
10.

Synthesis, Molecular Docking and Anticancer Activity of New Substituted Pyridine-1,2,3-Triazole Hybrid N-glycosides Via Click Chemistry

Volume 67, Issue 13, December 2024, Pages 1221-1233
Nora S. A. Al-Sahaly; Sewar Alghannay; Kaiss Aouadi; Mohamed N. El-Bayaa; Fahad M. Alminderej; Sobhi M. Gomha; Hussien H. Elganzory; Wael A. El-Sayed
11.

Relationship between Thyroid Functions and Estimated Glomerular Filtration Rate in Patients with Chronic Kidney Disease

Volume 97, Issue 1, October 2024, Pages 4232-4239
12.

Insights into the Role of Fibroblasts in Non-small Cell Lung Cancer Cell Lines Progression as a Potential Therapeutic Target

Volume 8, Issue 3, July 2024, Pages 164-175
Nouran Ebid; Marwa Sharaky; Abeer Elkhoely; Engy El Morsy; Sherif Saad
13.

6-aminomethylpinostrobin Derivatives as Anti-breast Cancer: In Silico Insight

Volume 67, Issue 7, July 2024, Pages 71-81
Hadi Poerwono; Melanny Ika Sulistyowati; Mohammad Rizki Fadhil Pratama
14.

Recent Studies on Aromatase and EGFR Involved in Breast Cancer and their Inhibitors

Volume 7, Issue 1, April 2024
Fiby Nabil Takla; Waleed Bayoumi; Shahenda El-messery; Magda Nasr
15.

A review of computational studies and bioinformatics analysis of effective drug as an inhibitor against EGFR/VEGFR-2 kinases

Volume 2024, Issue 1, April 2024, Pages 143-155
Mona H. Ibraheim; Ibrahim Maher; Ibrahim Khater
16.

Hydantoin derivatives: A review on their anticancer activities

Volume 4, Issue 1, January 2024, Pages 61-74
Moamen A. Hassanin; Muhamad Mustafa; Heba A. Hassan; Eman A Beshr; Ahmed T. M. Elshennawy; Omar M. Aly
17.

Cognitive status in chronic kidney disease elderly patients.

Volume 10, Issue 2, October 2023, Pages 128-136
Yumna Elgazzar; Tomader Abdel Rahman; Hala Sweed; Heba Kamel
18.

EXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS

Volume 68, Issue 2, September 2023, Pages 82-110
Abdelsalam Mohamed Ouf; Adel A Marzouk; Montaser A Shykhoon; Mohamed Ayman ALy El-Zahabi
19.

Targeted Therapy in Non-Small Cell Lung Cancer: Review Article

Volume 92, Issue 1, July 2023, Pages 6207-6212
20.

In vitro cytotoxic potential of Nephthea sp. and its silver nanoparticles against hepatic and colon cancer cells assisted with molecular docking studies

Volume 6, Issue 2, April 2023, Pages 86-89
John Refaat Fahim; Omnia Hisham Abdelhafez; Asma M. AboulMagd; Usama Ramadan Abdelmohsen; samar yehia desoukey; Mohamed Salah Kamel
21.

RECENT ADVANCES ON PYRIMIDINE DERIVATIVES AS ANTICANCER AGENTS.

Volume 67, Issue 1, March and April 2023, Pages 51-67
Hazem Mahdy; Hany Elnagar; Helmy Sakr
22.

Antitumor Potential Effect of Graviola Leaves Extracts on the MDA-MB-231 Cell Line

Volume 8, Issue 1, January 2023, Pages 47-52
Tito N. Habib; El-Sabry Abu Amra; Ahmed R.H. Ahmed; Gehad S. Mokhtar
23.

RECENT ADVANCES IN DRUGS TARGETING PROTEIN KINASES FOR CANCER THERAPY.

Volume 66, Issue 2, September and October 2022, Pages 56-86
Hazem Mahdy; Mahmoud Shaat; rezk Ayyad
24.

STUDY OF THE EFFECT OF SOFOSBUVIR BASED THERAPY ON ESTIMATED GLOMERULAR FILTRATION RATE IN EGYPTIAN CHRONIC HEPATITIS C PATIENTS

Volume 42, Issue 2, December 2021, Pages 7-13
Elsaied Ibrahim; Mohamed Ahmed Elbealy; Abeer Abdelhafeez Nassar; Hanan Mostafa Mostafa
25.

The Metabolic Mechanism Underlying the Enhancing Effects of Glycine and Tryptophan on Kidney Function: How to Reduce EGFR Inhibitory Effect on AAs

Volume 13, Issue 2, December 2021, Pages 37-48
Sania K. Elwia; Sahar M. Abo El Wafa; Yasmin M. Marei
First Page Previous Page 1 2 Next Page Last Page